Paychex Director Joseph Tucci Receives Annual Equity Grant
PAYCHEX INC
Subscribe to track PAYX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction Report: Paychex, Inc. (NASDAQ: PAYX)
**Insider:** Joseph M. Tucci
**Role:** Director
**Date of Transaction:** 2026-10-15
**Filing Date:** 2026-10-16
### Non-Derivative Transaction
- **Security:** Common Stock
- **Transaction Type:** Grant / Award (Code A)
- **Shares Acquired:** 970
- **Price:** $0.00
- **Direct Ownership After:** 68,334 shares
### Derivative Transactions
- **Security:** Stock Option (Right to Buy)
- **Options Granted:** 4,040
- **Exercise Price:** $110.78
- **Expiration Date:** 2036-10-14
**Significance:** Low (Routine annual director compensation equity grant)
Comprehensive Analysis
Executive Summary
On October 16, 2026, Paychex, Inc. (PAYX) filed a Form 4 detailing an equity award granted to board member Joseph M. Tucci on October 15, 2026. The transaction consists of 970 restricted stock units (RSUs) awarded at zero cost and 4,040 stock options granted at an exercise price of $110.78 per share.
Transaction Breakdown
- Restricted Stock Units: 970 shares of Common Stock were awarded under the company's Amended and Restated 2002 Stock Incentive Plan, bringing Mr. Tucci's direct shareholdings to 68,334 shares.
- Stock Options: 4,040 stock options with an exercise price of $110.78 were granted, vesting on October 15, 2027, and expiring on October 14, 2036.
Market & Trading Significance
This filing represents standard, scheduled non-employee director compensation under Paychex's equity incentive framework. Because this transaction reflects an award grant rather than open-market buying or selling activity, it carries Low trading significance for investors.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.